CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 187019-187188 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T76072","span":{"begin":0,"end":169},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Only 6.5% of primary tumor sites in severe combined immune deficiency patients involved the CNS in the Immunodeficiency Cancer Registry that was instituted in the 1970s."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T385","span":{"begin":0,"end":169},"obj":"Sentence"}],"text":"Only 6.5% of primary tumor sites in severe combined immune deficiency patients involved the CNS in the Immunodeficiency Cancer Registry that was instituted in the 1970s."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1703","span":{"begin":21,"end":26},"obj":"Disease"},{"id":"T1704","span":{"begin":103,"end":119},"obj":"Disease"},{"id":"T1705","span":{"begin":120,"end":126},"obj":"Disease"},{"id":"T1706","span":{"begin":141,"end":144},"obj":"Disease"}],"attributes":[{"id":"A1703","pred":"mondo_id","subj":"T1703","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A1704","pred":"mondo_id","subj":"T1704","obj":"http://purl.obolibrary.org/obo/MONDO_0021094"},{"id":"A1705","pred":"mondo_id","subj":"T1705","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A1706","pred":"mondo_id","subj":"T1706","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"Only 6.5% of primary tumor sites in severe combined immune deficiency patients involved the CNS in the Immunodeficiency Cancer Registry that was instituted in the 1970s."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T787","span":{"begin":21,"end":26},"obj":"Phenotype"},{"id":"T788","span":{"begin":52,"end":69},"obj":"Phenotype"},{"id":"T789","span":{"begin":103,"end":119},"obj":"Phenotype"},{"id":"T790","span":{"begin":120,"end":126},"obj":"Phenotype"}],"attributes":[{"id":"A787","pred":"hp_id","subj":"T787","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A788","pred":"hp_id","subj":"T788","obj":"http://purl.obolibrary.org/obo/HP_0002721"},{"id":"A789","pred":"hp_id","subj":"T789","obj":"http://purl.obolibrary.org/obo/HP_0002721"},{"id":"A790","pred":"hp_id","subj":"T790","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Only 6.5% of primary tumor sites in severe combined immune deficiency patients involved the CNS in the Immunodeficiency Cancer Registry that was instituted in the 1970s."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T348","span":{"begin":92,"end":95},"obj":"Body_part"}],"attributes":[{"id":"A348","pred":"uberon_id","subj":"T348","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"}],"text":"Only 6.5% of primary tumor sites in severe combined immune deficiency patients involved the CNS in the Immunodeficiency Cancer Registry that was instituted in the 1970s."}